Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
4
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer immunotherapy
clinical trials
ipo
biogen
deerfield management
europe blog main
europe top stories
forty seven
gilead sciences
melinta therapeutics
nivolumab
What
ipo
4
×
bio
roundup
companies
covid
life
medicines
new
science
sciences
week
acquisitions
activity
announced
approvals
arena’s
biogen
biotechs
bounty
ceo
cig
clamped
club
collabs
comeback
continued
corner
crop
daniel
deal
deals
delays
delivered
developing
economic
exceeded
expressing
fast
fda
firms
Language
unset
Current search:
ipo
×
cancer
×
" seattle blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
